Patalinghug, Shella Mae J.

HRN: 18-78-54  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2022
CEFUROXIME 750MG (VIAL)
10/04/2022
10/10/2022
IV
375
Q8
Wound Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: